Solasto Corporation

6197.T
Medical Care Facilities
2026/08/21 Updated
Market Cap: $636.8M (¥101.2B)
Stock Price: $7.03 (¥1,118)
Exchange Rate: 1 USD = ¥158.98

【Solasto】Notice of Director Appointment | May 27, 2026

On May 27, 2026, Solasto announced the appointment of new directors. Several new executives have been appointed, with the selection reason involving leveraging diverse expertise and experience.

Importance:
Page Updated: May 27, 2026
IR Disclosure Date: May 27, 2026

Key Figures

  • Number of directors: Unknown (multiple new directors appointed)
  • Date of appointment: May 27, 2026
  • Effective date: Immediately

AI要約

Overview of Executive Personnel Changes

On May 27, 2026, Solasto appointed new directors, with multiple executives taking office. The new directors include individuals with extensive experience in corporate management and organizational operations, aimed at enhancing management diversity and expertise. The appointment is expected to contribute to advancing future business strategies and increasing corporate value, with the effective date from the same day.

Background and Future Outlook of Executive Personnel Changes

These personnel changes were implemented as part of Solasto’s medium- to long-term growth strategy. The appointment of new directors aims to strengthen corporate governance and improve management transparency, while incorporating new perspectives and ideas into the management to boost business competitiveness. Further refreshment of executives and review of personnel systems will continue to be carried out to pursue sustainable growth.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Solasto

Company overview · Stock price · Financial data · All IR

View company page →